Off-label use of immune checkpoint inhibitors for the treatment of solid tumors: analysis of a nationwide patient sample

Purpose Immune checkpoint inhibitors (ICIs) have become an indispensable part of clinical practice; however, off-label use of these agents is unknown. We aimed to define the patterns of off-label use of ICIs in a nationwide sample of patients. Methods The online database (Reçetem) was retrospectivel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2023-09, Vol.149 (11), p.8655-8662
Hauptverfasser:	Kandemir, Esin Aysel, Karaomerlioglu, Irem, Yaradilmis, Ibrahim Muaz
Format:	Artikel
Sprache:	eng
Schlagworte:	adults Cancer Cancer Research Carcinoma, Non-Small-Cell Lung - pathology ethics Female guidelines Head & neck cancer Head and neck carcinoma head and neck neoplasms Hematology Hepatocellular carcinoma hepatoma Humans Immune checkpoint inhibitors Immune Checkpoint Inhibitors - therapeutic use Immunotherapy - methods Internal Medicine Kidney cancer kidney neoplasms lung neoplasms Lung Neoplasms - pathology Male males Medicine Medicine & Public Health Melanoma Metastases metastasis Nivolumab - therapeutic use Non-small cell lung carcinoma Off-Label Use Oncology Patients Pembrolizumab Retrospective Studies Small cell lung carcinoma Solid tumors Statistical analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!